Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study
Abstract The aim of this study was to investigate optimal loading doses prior to continuous infusion of meropenem in critically ill patients. A previously published and successfully evaluated pharmacokinetic model of critically ill patients was used for stochastic simulations of virtual patients. Ma...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/35be4501d4fa47959d11c96691e45305 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:35be4501d4fa47959d11c96691e45305 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:35be4501d4fa47959d11c96691e453052021-12-02T16:34:53ZOptimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study10.1038/s41598-021-96744-32045-2322https://doaj.org/article/35be4501d4fa47959d11c96691e453052021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-96744-3https://doaj.org/toc/2045-2322Abstract The aim of this study was to investigate optimal loading doses prior to continuous infusion of meropenem in critically ill patients. A previously published and successfully evaluated pharmacokinetic model of critically ill patients was used for stochastic simulations of virtual patients. Maintenance doses administered as continuous infusion of 1.5–6 g/24 h with preceding loading doses (administered as 30 min infusion) of 0.15–2 g were investigated. In addition to the examination of the influence of individual covariates, a best-case and worst-case scenario were simulated. Dosing regimens were considered adequate if the 5th percentile of the concentration–time profile did not drop at any time below four times the S/I breakpoint (= 2 mg/L) of Pseudomonas aeruginosa according to the EUCAST definition. Low albumin concentrations, high body weight and high creatinine clearances increased the required loading dose. A maximum loading dose of 0.33 g resulted in sufficient plasma concentrations when only one covariate showed extreme values. If all three covariates showed extreme values (= worst-case scenario), a loading dose of 0.5 g was necessary. Higher loading doses did not lead to further improvements of target attainment. We recommend the administration of a loading dose of 0.5 g meropenem over 30 min immediately followed by continuous infusion.Uwe LiebchenHanna SalletmeierSimon KalleeChristina ScharfLucas HuebnerAlexandra WeberMichael ZollerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-6 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Uwe Liebchen Hanna Salletmeier Simon Kallee Christina Scharf Lucas Huebner Alexandra Weber Michael Zoller Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study |
description |
Abstract The aim of this study was to investigate optimal loading doses prior to continuous infusion of meropenem in critically ill patients. A previously published and successfully evaluated pharmacokinetic model of critically ill patients was used for stochastic simulations of virtual patients. Maintenance doses administered as continuous infusion of 1.5–6 g/24 h with preceding loading doses (administered as 30 min infusion) of 0.15–2 g were investigated. In addition to the examination of the influence of individual covariates, a best-case and worst-case scenario were simulated. Dosing regimens were considered adequate if the 5th percentile of the concentration–time profile did not drop at any time below four times the S/I breakpoint (= 2 mg/L) of Pseudomonas aeruginosa according to the EUCAST definition. Low albumin concentrations, high body weight and high creatinine clearances increased the required loading dose. A maximum loading dose of 0.33 g resulted in sufficient plasma concentrations when only one covariate showed extreme values. If all three covariates showed extreme values (= worst-case scenario), a loading dose of 0.5 g was necessary. Higher loading doses did not lead to further improvements of target attainment. We recommend the administration of a loading dose of 0.5 g meropenem over 30 min immediately followed by continuous infusion. |
format |
article |
author |
Uwe Liebchen Hanna Salletmeier Simon Kallee Christina Scharf Lucas Huebner Alexandra Weber Michael Zoller |
author_facet |
Uwe Liebchen Hanna Salletmeier Simon Kallee Christina Scharf Lucas Huebner Alexandra Weber Michael Zoller |
author_sort |
Uwe Liebchen |
title |
Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study |
title_short |
Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study |
title_full |
Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study |
title_fullStr |
Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study |
title_full_unstemmed |
Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study |
title_sort |
optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/35be4501d4fa47959d11c96691e45305 |
work_keys_str_mv |
AT uweliebchen optimalloadingdoseofmeropenembeforecontinuousinfusionincriticallyillpatientsasimulationstudy AT hannasalletmeier optimalloadingdoseofmeropenembeforecontinuousinfusionincriticallyillpatientsasimulationstudy AT simonkallee optimalloadingdoseofmeropenembeforecontinuousinfusionincriticallyillpatientsasimulationstudy AT christinascharf optimalloadingdoseofmeropenembeforecontinuousinfusionincriticallyillpatientsasimulationstudy AT lucashuebner optimalloadingdoseofmeropenembeforecontinuousinfusionincriticallyillpatientsasimulationstudy AT alexandraweber optimalloadingdoseofmeropenembeforecontinuousinfusionincriticallyillpatientsasimulationstudy AT michaelzoller optimalloadingdoseofmeropenembeforecontinuousinfusionincriticallyillpatientsasimulationstudy |
_version_ |
1718383744140705792 |